avapro has been researched along with Central Nervous System Diseases in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xing, G | 1 |
| Wei, M | 1 |
| Xiu, B | 1 |
| Ma, Y | 1 |
| Liu, T | 1 |
1 other study available for avapro and Central Nervous System Diseases
| Article | Year |
|---|---|
[Irbesartan reduces inflammatory response of central nervous system in a rat model of fluid percussion brain injury].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Brain; Brain Injuries; Carbon | 2016 |